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Abstract
Purpose Although Roux-en-Y gastric bypass (RYGB) is the main primary bariatric procedure, it has also been utilized as
revisional bariatric surgery. Our aim is to compare revisionary gastric bypass with primary gastric bypass through systematic
review with meta-analysis.
Methods Available literature was searched for eligible studies up to December 2017. Inclusion criteria were reports onmorbidity,
%EWL, or diabetes remission. Secondary outcomes involved mortality, anastomotic leakage, operative time, and length of
hospital stay. Random effect meta-analyses were undertaken.
Results Initial search yielded 1164 references. Final meta-analysis involved 21 studies and revealed significant differences in
terms of morbidity (RR1.54, p < 0.001) and EWL (WMD-19.9, p < 0.001). There were no differences in diabetes remission.
Conclusion Revisionary RYGB has worse weight loss effect with greater morbidity rate than primary RYGB.
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Introduction
A significant proportion of patients undergoing bariatric pro-
cedures fail to achieve their weight loss goal, regain weight, or
develop procedure-related complications. The failure rate is
estimated to be as high as 40% and is closely related to
primary procedure, patients’ characteristics, and their compli-
ance with postoperative dietary habits [1–3]. According to
published data, up to a quarter of patients undergoing bariatric
surgery will require revisional surgery within 10 years after
primary treatment [4, 5]. Given the increasing number of pri-
mary bariatric procedures performed worldwide, it may lead
to a significant clinical problem.
For a long time, the Roux-en-Y gastric bypass (RYGB) has
been the gold standard in the treatment of obesity and remains
one of the most commonly performed bariatric procedures. Its
excellent weight loss effect, together with successful impact
on obesity-related comorbidities, has been well documented
in the literature [6]. The RYGB has also been utilized as
revisional surgery after failed primary procedure, with encour-
aging results. However, there are still no clear guidelines on
the optimal revisional procedure. This is mostly due to limited
data on long-term results of revisional procedures. Moreover,
revisional surgeries are more complex [7, 8]. Only recently
have long-term outcomes of revisional and primary RYGB
been compared. To evaluate safety and results, we have
attempted a systematic review of the available literature in
order to assess the morbidity, mortality, and long-term results
of revisional RYGB in comparison to that of primary RYGB.
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A systematic review of the literature was performed using the
Medline, Embase, and Cochrane databases to identify all eli-
gible studies that compared patients undergoing primary
RYGB with revisionary Roux-en-Y gastric by-pass
(RRYGB). The used search terms included the following:
Brevision,^ Breoperation,^ Bre-do,^ Bgastric by-pass,^
BLRYGB,^ BRYGB,^ Bprimary,^ Boriginal,^ and Bfirst.^
These terms were combined using Boolean operators
BAND^ and BOR.^ Some references of the acquired articles
were also located manually. The most recent search was per-
formed on 12 December 2017. Ovid search strategy is avail-
able in supplementary file 1.
Studies eligible for further analysis had to fulfill the fol-
lowing criteria: (1) comparison of EWL between patients
undergoing RYGB and RRYGB or (2) an objective evalua-
tion of overall morbidity or (3) diabetes mellitus (DM) re-
mission (4) publication in English. Studies were excluded
when there was (1) lack of comparative data, (2) lack of
primary outcomes or insufficient data to analyze, and (3) a
procedure other than RYGB.
Outcomes of Interest
Primary outcomes of interest were overall morbidity, % of lost
excess weight (EWL), and DM remission. Secondary out-
comes of interest involved mortality rate, anastomotic leakage
rate, hypertension remission, operative time, and length of
hospital stay.
Data Extraction and Quality Assessment
All references were reviewed and evaluated by two teams of
two researchers. In case of any doubts about eligibility for in-
clusion, an attempt was made to reach consensus within the
group. If no resolution was possible, an arbitrary decision was
made by another reviewer. Data from included studies were
extracted independently by all teams. Only full-length articles
were eligible for extraction. When available, the following data
were extracted: first author, year of publication, country, num-
ber of operated subjects, and outcomes of interest.
Non-randomized studies were evaluated according to the
Newcastle–Ottawa Scale (NOS), which consists of three fac-
tors: patient selections, comparability of study groups, and
assessment of outcomes. A score of 0 to 9 was assigned to
each study, and studies achieving a score of 6 or higher were
considered high-quality. This study was performed according
to the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines and Meta-Analysis of
Observational Studies in Epidemiology (MOOSE) consensus
statement [9, 10]. The study was registered in the PROSPERO
Database and the assigned number is CRD42018087537.
Data Analysis
Analysis was performed using RevMan 5.3 (freeware from The
Cochrane Collaboration). Statistical heterogeneity and incon-
sistency were measured using Cochran’s Q tests and I2, respec-
tively. Qualitative outcomes from individual studies were ana-
lyzed to assess individual and pooled risk ratios (RR) with
pertinent 95% confidence intervals (CI) favoring patients un-
dergoing revisionary surgery, and by means of the Mantel–
Haenszel random-effects method. When appropriate, mean
and standard deviation were calculated frommedians and inter-
quartile ranges using a method proposed by Hozo et al. [11].
Weighted mean differences (WMD) with a 95%CI are present-
ed for quantitative variables using the inverse variance random-
Fig. 1 PRISMA flowchart
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effects method. Statistical significance was observed with two-
tailed 0.05 level for hypotheses and with 0.10 for heterogeneity
testing, while unadjusted p values were reported accordingly.
Dichotomous outcome analysis involved subgroup analysis for
case-control and case-matched studies. EWL analysis involved
subgroups in regard to the length of follow-up, 1 and 2 years.
Results
An initial reference search yielded 1164 articles. After re-
moving 492 duplicates, 672 articles were evaluated
through titles and abstracts. This produced 49 papers suit-
able for full-text review. Finally, we narrowed this down to
21 studies eligible for data extraction, with a combined
total of 14,763 patients (3043 in RRYGB group and
11,720 in RYGB group) [1, 12–31]. A flowchart of the
analyzed studies is presented in Fig. 1. Quality of the an-
alyzed studies is moderate, with majority scoring at least 7
points according to NOS. Baseline information about the
analyzed studies is presented in Table 1. The funnel plot of
publication bias is presented in supplementary file 2. The
cone is symmetrical which suggests low risk of publication
bias. BMI prior to surgery was reported in 18 studies (45.3
vs. 43.3 kg/m2). Baseline BMI in patients undergoing
revisional surgery (before primary procedure) was reported
only in 8 of 21 analyzed studies, and also, no significant
differences were observed (48.3 vs. 46 kg/m2, p = 0.14).
Morbidity was reported in 13 studies, of which 5 were
case-matched. Analysis revealed higher rate of complica-
tions in revisionary patients (241/1294, 18.6% in RRYGB
vs. 526/6115, 8.6% in RYGB). In total, there were statisti-
cally significant differences between analyzed groups (RR
1.54, 95%CI 1.22–1.95, p = 0.0003); however, subgroup
analysis did not find any differences in case-matched stud-
ies (95%CI 0.83–2.56, p = 0.19). The overall heterogeneity
was moderate, I2 = 44% (Fig. 2).
Weight loss was reported in 15 studies; however, some of
them reported different periods of follow-up. To avoid po-
tential bias caused by this, for meta-analysis, we chose pub-
lications which reported 1- and 2-year periods of follow-up.
In the end, we included seven studies. Analysis revealed
significant differences in weight loss between groups
(WMD − 19.9, 95%CI − 25.56–− 14.24). Subgroup
Table 1 Baseline information
Study Year Type Country Access Total number
of patients
Primary surgery Quality score
according to
NOS scale
Topart [29] 2008 CC France Lap 259 AGB 7
Cadière [14] 2010 CC Belgium Lap 470 AGB, VBG 7
Radtka [23] 2010 CC USA Lap/open 928 VBG, RYGB 8
Zingg [31] 2010 CM Australia Lap/open 122 AGB, VBG, RYGB, SG 9
Deylgat [19] 2012 CC Belgium Lap/open 724 AGB, VBG, SG, RYGB, BPD-DS 8
Slegtenhorst [26] 2012 CC The Netherlands Lap/open 292 AGB 8
Stefanidis [1] 2013 CC USA ND 1206 AGB 7
Mor [22] 2013 CM USA ND 111 MGB, VBG, AGB, RYGB, SG, JIB 8
Thereaux [28] 2014 CC France Lap 1008 AGB 7
Thereaux [27] 2014 CM France Lap 90 AGB 6
Zhang [30] 2014 CM USA Lap/open 344 RYGB, VBG, AGB, SG 7
Delko [18] 2014 CM Switzerland Lap 96 AGB 9
Mohos [21] 2014 CM Hungary Lap 88 AGB, SG, RYGB, VBG 9
Sadot [25] 2015 CM Israel Lap 126 AGB 7
Coblijn, de Raaff [16] 2016 CC The Netherlands Lap 1130 ABG, SG 8
Coblijn, Lagarde [17] 2016 CC The Netherlands Lap 1667 SG, ABG 7
Raftopoulos [24] 2016 CC Greece Lap 820 ND 4
Al-Kurd [12] 2017 CM Israel Lap 322 AGB 7
Axer [13] 2017 CM Sweden Lap/open 4836 VBG, AGB, GB, SG, GBP, JIB 8
Chowbey [15] 2017 CM India Lap 60 SG, AGB 7
Malinka [20] 2017 CM Switzerland Lap 64 SG 7
CC case control, CM case matched, AGB laparoscopic adjustable gastric banding, VBG vertical banded gastroplasty surgery, RYGB Roux-en-Y gastric
bypass, SG sleeve gastrectomy, BPD-DS biliopancreatic diversion with duodenal switch,MGBmini-gastric bypass, JIB jejunal–jejunal bypass,GB fixed
gastric banding, ND no data
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analysis showed similar results. The heterogeneity in total
and in 1-year group was very high. Sensitivity analysis did
not find study generating inconsistence (Fig. 3).
DM remission was reported in seven studies. There were no
significant differences in analyzed material, both in total and in
subgroups (RR 1.05, 95%CI 0.81–1.43, p = 0.61). The hetero-
geneity in case-control subgroup was moderate, whereas in
case-matched subgroup, there was no heterogeneity (Fig. 4).
Mortality was reported in 16 studies. Mortality rate was
significantly greater in revisionary group, 9/1443 (0.62%) ver-
sus 12/5720 (0.21%); RR 3.03, 95%CI 1.16–7.89, p = 0.02.
However, subgroup analysis revealed no differences in case-
matched subgroup (95%CI 0.31–26.07), whereas the low end
of 95%CI was just slightly above 1 (95%CI 1.04–9.18). The
heterogeneity in this outcome was low, both within total and
within subgroups (Fig. 5).
Fig. 2 Pooled estimates of morbidity rate comparing revisionary gastric bypass versus primary gastric bypass. CI confidence interval, df
degrees of freedom
Fig. 3 Pooled estimates of %EWL comparing revisionary gastric bypass versus primary gastric bypass. CI confidence interval, df degrees of freedom
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Anastomotic leakagewas reported in 14 studies. Analysis
revealed significant differences in total (RR 3.05, 95%CI
1.7–5.49, p = 0.0002) and in case-matched subgroup (RR
3.92, 95%CI 1.75–8.81, p = 0.0009). The heterogeneity in
total and in case-matched subgroup was low (Fig. 6). There
were no significant differenceswithin case-control subgroup
(95%CI 0.72–6.81).
Hypertension remission was reported in seven studies.
There were no significant differences between analyzed
group, both within total and within subgroups, 154/357
Fig. 4 Pooled estimates of diabetes mellitus remission comparing revisionary gastric bypass versus primary gastric bypass. CI confidence interval, df
degrees of freedom
Fig. 5 Pooled estimates of mortality rate comparing revisionary gastric bypass versus primary gastric bypass. CI confidence interval, df
degrees of freedom
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(43.14%) versus 525/1413 (37.15%), 95%CI 0.8–1.14
(Fig. 7). The heterogeneity was moderately low in case-
matched subgroup and low in case-control subgroup.
Operative time was reported in seven studies. Primary sur-
geries were significantly shorter by 44.57 min (WMD 44.57,
95%CI 27.14–62.01, p = 0.00001). However, the
heterogeneity was very high and sensitivity analysis did not
provide resolution (Fig. 8).
Length of hospital stay was reported in eight studies.
There were no significant differences (95%CI − 0.49—
1.94, p = 0.24); however, the heterogeneity was very high,
I2 = 98% (Fig. 9).
Fig. 6 Pooled estimates of anastomotic leakage comparing revisionary gastric bypass versus primary gastric bypass. CI confidence interval, df
degrees of freedom
Fig. 7 Pooled estimates of hypertension remission rate comparing revisionary gastric bypass versus primary gastric bypass. CI confidence
interval, df degrees of freedom
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Discussion
To our knowledge, this is the first systematic review compar-
ing outcomes of primary and revisional laparoscopic Roux-
en-Y gastric bypass (LRYGB). The main findings show that
revisions are associated with higher overall morbidity, in-
creased mortality, and worse weight loss effect when com-
pared to primary procedures. Operations last longer, but they
are not associated with longer hospital stay. In addition, there
were no differences in the postoperative effect on the resolu-
tion of obesity-related complications, such as diabetesmellitus
or hypertension.
The majority of patients in the investigated studies
underwent revision after adjustable gastric band (ABG)
or vertical banded gastroplasty (VBG). It is in line with
previous observations that showed disappointing results
and failure rate up to 60% in long-term observation.
This has led to a rapid decline in the number of ABG
performed in recent years [32, 33]. Nevertheless, the num-
ber of ABG patients remains high, and one can expect that
the majority of them at some point will require revision.
We observed that morbidity, including anastomotic leak-
age, is higher in patients undergoing revisional LRYGB.
This is in line with the study by Worni et al., who used the
Nationwide Inpatient Sample (not included in our review
due to exclusion criteria) and observed an increased num-
ber of adverse events (OR 8.0) [34]. In our review, the
difference was lower (RR 1.54); however, it is still pres-
ent. Interestingly, when a subgroup of case-matched
patients was analyzed, no difference in morbidity was
noted. In the majority of the studies, adverse events were
reported up to 30 days after surgery, which may have
introduced bias. The reported leakage rate of 1.39% after
primary and 4.3% after revisions is within the range re-
ported by other investigators [35–38].
Moreover, we noticed an increased mortality rate in the
revisional group, but as in the case of morbidity, this increase
was not present when case-matched studies were analyzed
separately. On the one hand, this unequivocally confirms the
higher risk of revisional surgery; on the other—the numbers
are still low (0.2 vs. 0.6% mortality). Wide 95% confidence
intervals (1.16–7.89) confirm the fragility of this finding. Our
results show that every revisional patient should be well in-
formed about the potentially higher risk of adverse events
during the second procedure.
The main purpose of this review is to answer the question
whether LRYGB may serve as a revisional procedure.
Although weight loss was found in the majority of studies,
meta-analysis including all of them was not possible due to
differences in follow-up intervals and differences in reporting
weight loss (simple weight loss, excess weight loss, excess
body mass index loss, etc.). For these reasons, we were only
able to group studies that reported EWL after 12 and
24 months. Patients after RRYGB lost on average 20% less
of the excess weight than after primary procedure. It is an
important observation taking into consideration that the pre-
operative BMI of the patients was comparable (45.3 vs.
43.3 kg/m2). However, baseline BMI in patients undergoing
Fig. 8 Pooled estimates of operative time comparing revisionary gastric bypass versus primary gastric bypass. CI confidence interval, df
degrees of freedom
Fig. 9 Pooled estimates of length of hospital stay comparing revisionary gastric bypass versus primary gastric bypass. CI confidence interval,
df degrees of freedom
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revisional surgery (before primary procedure) was reported
only in 8 of 21 analyzed studies. There were also no signifi-
cant differences (48.3 vs. 46 kg/m2, p = 0.14). Therefore, these
results cannot be taken universally. It is likely that patients
after revision had higher initial BMI, which might have influ-
enced long-term outcomes because preoperative BMI is a
well-known variable that is associated with postoperative
weight loss [39].
Not all studies reported resolution of obesity-related
diseases. Among those that did, we were not able to find
any differences in meta-analysis. Primary and revisional
RYGB had the same impact on DM and hypertension
status after surgery. Based on our meta-analysis, we can
assume that the metabolic effect is equal regardless of the
previous bariatric treatment. However, this finding must
be interpreted with caution because we were not able to
provide any additional data on the severity of DM and
hypertension. It is likely that there were differences be-
tween groups. Therefore, this issue needs to be investigat-
ed further.
In addition to primary outcomes, we decided to analyze the
operative time and length of hospital stay. Unsurprisingly,
revisional surgery takes longer (additional 44 min in the me-
ta-analysis). In our opinion, this parameter is of little relevance
since the surgeon’s experience was not analyzed in any way. It
is obvious that revisions are considered more demanding, and
for this reason, more advanced surgeons are selected. It is not
clear whether it has any impact on clinical outcomes. There
are studies showing that prolonged operative time may lead to
the development of specific complications such as rhabdomy-
olysis [40].
The length of hospital stay was indifferent between
groups. The I2 of 98% shows there are major differences
in the postoperative stay in the hospital. None of the studies
provided details on perioperative care. Taking into consid-
eration the rapid changes in perioperative care and their
influence on outcomes (introduction of enhanced recovery
protocols), we consider this parameter to be no longer a
reliable clinical benchmark [41, 42].
This review has some rather obvious shortcomings. It
comprises only retrospective studies. However, this is the
best available evidence since randomization is not possible.
We did not analyze indications for revisional surgery
(weight regain/complications of primary surgery), and per-
haps, this aspect and better patient selection might help in
improving the quality of future evidence. Moreover, we did
not find information on the surgeon’s experience and insti-
tutional volume as well as the operative technique used. We
assume that there might have been variation in the experi-
ence of surgeons performing primary and revisional sur-
gery, since the latter is considered more difficult. This might
have contributed to biased results. Four studies included
patients undergoing both laparoscopic and open surgery
which, to some extent, might have biased the results. We
realize that the majority (> 95%) of RYGB are currently
performed laparoscopically; therefore, further analyses
should perhaps select only minimally invasive cases.
However, when choosing inclusion criteria and building
search strategy, surgical access was not limited and so we
decided to follow initial assumptions. Additionally, our
study did not analyze the initial BMI before primary surger-
ies, which may affect EWL after revisional procedures.
Conclusion
This is the first systematic review attempting to show that
revisional RYGB is associated with worse short- and long-
term surgical outcomes when compared to primary procedures.
It includes case-control and case-matched studies. The quality
of included studies in general was moderate. Despite the higher
morbidity and mortality in revisional group, these parameters
are still relatively low. Moreover, the worse bariatric effect in
terms of excess weight loss was observed after revision, but
there were no differences in the resolution of obesity-related
diseases. Therefore, it seems that revisional RYGB will still
play a significant role as secondary procedure in patients who
failed to lose weight or developed complications after primary
surgery. In order to see which patients will particularly benefit
from revisional RYGB, further studies focused on strict inclu-
sion criteria and indications to surgery are required.
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